Dopamine Oxidation and Autophagy
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms involved in the neurodegenerative process of Parkinson's disease remain unclear. Currently, there is a general agreement that mitochondrial dysfunction, α -synuclein aggregation, oxidative stress, neuroinflammation, and impaired protein degradation are involved in the neurodegeneration of dopaminergic neurons containing neuromelanin in Parkinson's disease. Aminochrome has been proposed to play an essential role in the degeneration of dopaminergic neurons containing neuromelanin by inducing mitochondrial dysfunction, oxidative stress, the formation of neurotoxic α -synuclein protofibrils, and impaired protein degradation. Here, we discuss the relationship between the oxidation of dopamine to aminochrome, the precursor of neuromelanin, autophagy dysfunction in dopaminergic neurons containing neuromelanin, and the role of dopamine oxidation to aminochrome in autophagy dysfunction in dopaminergic neurons. Aminochrome induces the following: (i) the formation of α -synuclein protofibrils that inactivate chaperone-mediated autophagy; (ii) the formation of adducts with α - and β -tubulin, which induce the aggregation of the microtubules required for the fusion of autophagy vacuoles and lysosomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








![Figure 9 The effects of aminochrome on β-tubulin (a–d) and the accumulation of autophagosomes in the cytosol of cells treated with aminochrome (e). RCSN-3 cells were treated with cell culture medium (a), 100 μM dicoumarol (b), 50 μM aminochrome (c), and 50 μM aminochrome and 100 μM dicoumarol (d) and incubated for 48 h as described by Paris et al. 2010 [15]. In (e) the number of autophagosomes per cell was determined by incubating RCSN3 cells for 24 h with cell culture medium (Co), 100 μM dicoumarol (Di), 10 μM vinblastine (V), 20 μM aminochrome (AM), 20 μM aminochrome and 100 μM dicoumarol (AMDi), 20 μM aminochrome and 100 μM dicoumarol and 10 μM vinblastine (AMDiV). As a positive control, cells were incubated with cell culture medium without bovine serum (Co+). The statistical significance was assessed using ANOVA for multiple comparisons and Student's t test (***P < 0.001). This experiment was performed as described by Paris et al. 2011 [40].](https://figures.cochat.ai/paper-figures/6606d0df62c94c54aa8f4a98cd3360a9/dopamine-oxidation-and-autophagy-figure-9.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Further self-amplification would come from the facts that dopamine autooxidizes to give O2•− (219) and ONOO– also oxidizes dopamine (220).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [220]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 1×
“In familiar PD, the formation of neurotoxic α-synuclein protofibers is dependent on a specific point mutation [33].”
BackgroundParkin is recruited selectively to impaired mitochondria and promotes their autophagy
Narendra, D., Tanaka, A., Suen, D.-F., & Youle, R. J. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200809125 · Cited by 4,026 · cited 1×
“Parkin has also been shown to promote autophagy of damaged mitochondria by relocalizing into dysfunctional mitochondria with low membrane potentials in mammalian cells [68].”
BackgroundImpaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Interestingly, the pathogenic A53T and A30P α-synuclein mutants inhibit their own degradation and that of other substrates [64].”
BackgroundKinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
Epidemiology of Alzheimer Disease
Mayeux, R., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,064
GRAHAM, D. G., TIFFANY, S. M., BELL, W. R., & GUTKNECHT, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953
α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003122 · Cited by 825 · cited 1×
“α-synuclein impairs autophagy via Rab1a inhibition, and Rab1a overexpression rescues the autophagy defect caused by α-synuclein [66].”
BackgroundDopamine covalently modifies and functionally inactivates parkin
LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722 · cited 1×
“of the proteasomal system, by forming adducts with parkin [14] as well as inhibit the proteasome [76].”
BackgroundVogiatzi, T., Xilouri, M., Vekrellis, K., & Stefanis, L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801992200 · Cited by 683 · cited 1×
“Wild-type α-synuclein is degraded by chaperonemediated autophagy (CMA) and macroautophagy because the inhibition of CMA and macroautophagy lead to accumulation of wild type α-synuclein [62].”
BackgroundRole of autophagy in G2019S‐LRRK2‐associated neurite shortening in differentiated SH‐SY5Y cells
Plowey, E. D., Cherra, S. J., Liu, Y., & Chu, C. T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05217.x · Cited by 493 · cited 1×
“Transfection of the common G2019S LRRK2 mutation into SH-SY5Y cells was reported to increase autophagy in both neuritic and somatic compartments [70].”
Background
Research works printed but not linked: 5
- 1995, Biometals, 25, 795
- 2006, Society for Neuroscience, 824, article 17
- 2008, Neurotoxicity Research, 13, article 136
- 1984, Journal of Chromatography, 311, 154
- 2012, Cold Spring Harbor Perspectives in Medicine, 2, 1
Cited by
Items 101–200 of 214
Evaluation of the Cytotoxicity of Ayahuasca Beverages
Simão, A. Y., Gonçalves, J., Gradillas, A., García, A., Restolho, J., Fernández, N., Rodilla, J. M., Barroso, M., Duarte, A. P., Cristóvão, A. C., et al. (2020) · Molecules · doi:10.3390/molecules25235594 · Cited by 21
“Nevertheless, the accumulation of dopamine may contribute to its auto-oxidation, which in turn it is well known to account for the formation of neuromelanin and consequent neurodegeneration of dopaminergic neurons [19,20].”
Gallardo-Fernández, M., Ortega, R. H., Cerezo, A. B., Troncoso, A. M., & García-Parrilla, M. C. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113542 · Cited by 24
Catechol-bearing block copolymer micelles: Structural characterization and antioxidant activity
Hasegawa, U., Moriyama, M., Uyama, H., & van der Vlies, A. J. (2015) · Polymer · doi:10.1016/j.polymer.2015.03.080 · Cited by 24
Roussotte, F. F., Gutman, B. A., Hibar, D. P., Madsen, S. K., Narr, K. L., Thompson, P. M., & (ADNI), A. D. N. I. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.10.011 · Cited by 19
“Free cytosolic DA has protons that dissociate from their corresponding hydroxyl groups, promoting the oxidation of DA to dopamine quinones (DAQ) [35] and other free radicals.”
InfluentialSirota, T. V. (2015) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20156101115 · Cited by 19
Chemiexcitation: Mammalian Photochemistry in the Dark†
Brash, D. E., & Goncalves, L. C. P. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13781 · Cited by 16
“self-amplification would come from the fact that dopamine autooxidizes to give O2 – (220) and ONOO also oxidizes dopamine (221).”
BackgroundPsychostimulants influence oxidative stress and redox signatures: the role of DNA methylation
Sundar, V., Tamizhselvi, R., Doke, M., & Samikkannu, T. (2022) · Redox Report · doi:10.1080/13510002.2022.2043224 · Cited by 21
“However, 5-S-cysteinyldopamine is cytotoxic, as it triggers ROS production in human neuroblastoma (SH-SY5Y) cells [42,43].”
BackgroundOxidation and ubiquitination in neurodegeneration
Riederer, B. M., Leuba, G., & ElHajj, Z. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213488484 · Cited by 19
“For example, we can mention the sporadic formation of a toxic triad of tau, Aß and fyn in hippocampus and neocortex in AD,(50) the presence of abnormal phosphorylated neurofilaments in motoneurons in ALS,(38) the accumulation of huntingtin in the striatum in Huntington’s disease(53) or the formation of toxic aminochro…”
BackgroundOne-Electron Reduction of 6-Hydroxydopamine Quinone is Essential in 6-Hydroxydopamine Neurotoxicity
Villa, M., Muñoz, P., Ahumada-Castro, U., Paris, I. B., Jiménez, A., Martínez-Alcalá, I. M., Sevilla, F., & Segura‐Aguilar, J. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9382-7 · Cited by 16
Self-citationNeurotoxins as Preclinical Models for Parkinson’s Disease
Segura‐Aguilar, J. (2018) · Neurotoxicity Research · doi:10.1007/s12640-017-9856-0 · Cited by 18
Self-citationDOPA Homeostasis by Dopamine: A Control-Theoretic View
Kleppe, R., Waheed, Q., & Ruoff, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312862 · Cited by 16
“The complex, whose details are presently not known, possibly minimizes the oxidations of DA and DOPA by MAO and reactive oxygen species (ROS), respectively [10].”
BackgroundInfluentialRana, D., Colombani, T., Mohammed, H. S., Eggermont, L. J., Johnson, S., Annabi, N., & Bencherif, S. A. (2019) · Emergent Materials · doi:10.1007/s42247-019-00037-5 · Cited by 18
“This reaction is likely more favored than the oxidation of DA, which follows a more complex route and requires a higher activation energy [28].”
BackgroundRegulation of Oxidative Stress by Long Non-coding RNAs in Central Nervous System Disorders
Xu, X., & Zhang, Y. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.931704 · Cited by 16
Electrochemical biosensors for dopamine
Zhu, H., & Xu, G. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.120039 · Cited by 15
Segura-Aguilar, Sulzer, D., Zucca, F. A., & Zecca, L. (2019) · PubMed · Cited by 15
Zhao, B., & Zhao, B. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.02.010 · Cited by 17
Kimura, S., Sekiguchi, M., Watanabe, K., Hiwatari, M., Seki, M., Yoshida, K., Isobe, T., Shiozawa, Y., Suzuki, H., Hoshino, N., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245526 · Cited by 14
“Since this generation of ROS induces cytotoxicity and neurodegeneration, COMT, MAO, and VMAT2 play an important role in preventing dopamine oxidation in dopaminergic neurons [38].”
BackgroundExpression of Human L-Dopa Decarboxylase (DDC) under Conditions of Oxidative Stress
Lotsios, N. S., Arvanitis, N., Charonitakis, A., Mpekoulis, G., Frakolaki, E., Vassilaki, N., Sideris, D. C., & Vassilacopoulou, D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45120635 · Cited by 14
Bradner, J. M., Kalia, V., Lau, F. K., Sharma, M., Bucher, M. L., Johnson, M. A., Chen, M., Walker, D. I., Jones, D. P., & Miller, G. W. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab011 · Cited by 12
Loeffler, D. A., Aasly, J. O., LeWitt, P. A., & Coffey, M. P. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191630 · Cited by 13
“Multiple mechanisms are believed to 517 be involved, including decreased local antioxidant 518 concentrations [118], increased iron concentrations 519 [119], production of H2O2 (which may be converted 520 to hydroxyl radical via the Fenton reaction [120]) 521 and reactive dopamine quinones as byproducts of 522 dopamin…”
BackgroundCarving the senescent phenotype by the chemical reactivity of catecholamines: An integrative review
Golubev, A. G. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101570 · Cited by 12
Anti-VEGF Effect of Bioactive Indolic Compounds and Hydroxytyrosol Metabolites
Gallardo-Fernández, M., Cerezo, A. B., Ortega, R. H., Troncoso, A. M., & García-Parrilla, M. C. (2022) · Foods · doi:10.3390/foods11040526 · Cited by 13
“Additionally, MOPAL is part of dopamine metabolism [35,36].”
BackgroundCamargo, L. P., Pelissari, M. R. D. S., da Silva, P. R. C., Batagin‐Neto, A., Medeiros, R. A., Dias, M. A., & Dall’Antônia, L. H. (2022) · Molecules · doi:10.3390/molecules27196410 · Cited by 12
“Theoretical studies were conducted for dopamine at distinct redox, protonation, and states (DOP0 to DOP4) [59], including degraded structures (DOPo-quinone and DOPaminochrome) [60] (see structures in Figure S12).”
BackgroundOakes, H. V., Ketchem, S., Hall, A. N., Ensley, T., Archibald, K. M., & Pond, B. B. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.08.003 · Cited by 12
Passive controlled flow for Parkinson's disease neuronal cell culture in 3D microfluidic devices
Kane, K. I. W., Jarazo, J., Moreno, E. L., Fleming, R. M. T., & Schwamborn, J. C. (2020) · Organs-on-a-Chip · doi:10.1016/j.ooc.2020.100005 · Cited by 14
Mechanistic model-driven exometabolomic characterisation of human dopaminergic neuronal metabolismPreprint
Preciat, G., Wegrzyn, A. B., Moreno, E. L., Willacey, C. C. W., Modamio, J., Monteiro, F. L., Assal, D. C. E., Schurink, A., Oliveira, M. A. P., Zhang, Z., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.30.450562 · Cited by 13
“Following manual curation of the literature [52, 70, 71, 72, 73, 74, 75, 76, 77, 78], 9 metabolites and 49 reactions were added to the subsystem dopamine metabolism within Recon3D.”
MethodTan, H., Hubertus, S., Thomas, S., Lee, A. M., Gerhardt, S., Gerchen, M. F., Sommer, W. H., Kiefer, F., Schad, L. R., & Vollstädt‐Klein, S. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06301-7 · Cited by 12
Sochr, J., Cinková, K., & Švorc, Ĺ. (2014) · Cited by 10
Arashpour, R., Kashani, M. H. G., Ghorbanian, M. T., Lashkarbolouki, T., & Dehghan, R. (2016) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2016150354 · Cited by 11
“Recently, it was found that 6-OHDA was recognized as a good model for the early stages of PD, especially in terms of emotional and cognitive deficits (Munoz et al. 2012).”
Schindler, S., Aguiló‐Aguayo, N., Dornbierer, U., & Bechtold, T. (2019) · Industrial & Engineering Chemistry Research · doi:10.1021/acs.iecr.9b05603 · Cited by 10
A Chain Reaction of Adrenaline Autoxidation is a Model of Quinoid Oxidation of Catecholamines
Sirota, T. V. (2020) · BIOPHYSICS · doi:10.1134/s0006350920040223 · Cited by 10
Hayashi, J., Ton, J., Negi, S., Stephens, D. E. K. M., Pountney, D. L., Preiß, T., & Carver, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073700 · Cited by 12
“DA is highly susceptible to oxidation at physiological pH [21,22].”
Neuronal Vulnerability to Degeneration in Parkinson’s Disease and Therapeutic Approaches
Sharma, T., Kumar, R., & Mukherjee, S. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230426155432 · Cited by 9
The effect of fixed valence metal ions on the free radical process of epinephrine autoxidation
Sirota, T. V. (2016) · BIOPHYSICS · doi:10.1134/s000635091601022x · Cited by 9
Bertarini, L., Imbeni, F., Brighenti, V., Martusciello, I., Pellati, F., & Alboni, S. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00289 · Cited by 9
Mitra, R. S., Premraj, L., & Khoo, T. K. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105448 · Cited by 8
Sirota, T. V. (2019) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20196504316 · Cited by 8
Abubakar, M., Alom, S., Ali, F., Ali, S. R., Adhikary, K., Sarika, S., Gupta, P. K., Puppala, E. R., Murti, K., Nand, S., et al. (2026) · Current Neuropharmacology · doi:10.2174/011570159x446831260303200516 · Cited by 9
Tyrosine hydroxylase activity is regulated through the modification of the 176th cysteine residue
Inukai, S., Hara, S., & Ichinose, H. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.12.024 · Cited by 7
Khan, M. M. I., Baek, G. W., Kim, K., Kwon, H., & Jin, S. H. (2017) · Electroanalysis · doi:10.1002/elan.201700173 · Cited by 7
Dopamine oxidation to neuromelanin and neurotoxic metabolites
Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00002-2 · Cited by 8
Self-citationVázquez, Y. R., Alstyne, K. L. V., & Bingham, B. L. (2017) · Marine Biology · doi:10.1007/s00227-017-3228-4 · Cited by 7
“A variety of other reactions have been proposed, however (e.g., Graham 1978; Bindoli et al. 1992; Ito 2003; Napolitano et al. 2011; Muñoz et al. 2012).”
BackgroundFilošević, A., Jović, K., Pištan, E., & Waldowski, R. A. (2021) · Biomolecules · doi:10.3390/biom11030453 · Cited by 7
“Released synaptic DA is cleared either through transport back to the presynaptic neuron where it is packaged into vesicles to prevent auto-oxidation of DA [32], or is oxidized to dopamine quinone [39], as both mechanisms are aimed at terminating the stimulation of the postsynaptic neuron [46].”
BackgroundInfluentialAdetuyi, O. A., & Wimalasena, K. (2025) · Toxics · doi:10.3390/toxics13080637 · Cited by 6
“In addition, dysregulation of DA metabolism under these conditions could lead to accumulation of cytosolic DA, leading to its autoxidation followed by polymerization to produce neuromelanin [13,14].”
Nuclear redox processes in land plant development and stress adaptation
Zachgo, S. (2023) · Biological Chemistry · doi:10.1515/hsz-2022-0288 · Cited by 6
Neuromelanin-induced cellular stress and neurotoxicity in the pathogenesis of Parkinson's disease
Jakaria, M., & Cannon, J. R. (2025) · APOPTOSIS · doi:10.1007/s10495-025-02156-3 · Cited by 6
“2) [34, 35].”
Chowdhury, A., Acharyya, S., Das, S., Guha, P. K., & Roy, S. (2025) · Talanta · doi:10.1016/j.talanta.2025.128742 · Cited by 5
Singh, A. K., & Kundu, T. K. (2026) · ACS Omega · doi:10.1021/acsomega.5c00905 · Cited by 6
Bandookwala, M., Nemani, K. S., Chatterjee, B., & Sengupta, P. (2020) · Current Analytical Chemistry · doi:10.2174/1573411016666200131154202 · Cited by 5
Neuroprotective mechanisms against dopamine oxidation-dependent neurotoxicity
Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00005-8 · Cited by 5
Self-citationRole of Oxidative Stress in the Etiology of Parkinson’s Disease: Advanced Therapeutic Products
Lavrova, A., Gretskaya, N. M., & Безуглов, В. В. (2021) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162021050307 · Cited by 5
Franco, F. D. S., Peixoto, M. S., Felipe, A. D. S., & do Carmo, D. R. (2022) · Silicon · doi:10.1007/s12633-022-01659-x · Cited by 5
“DA = L-dopamine and DAQ = Product of L-dopamine oxidation (dopamine-quinone) [73, 74].”
BackgroundTsopela, V., Korakidis, E., Lagou, D., Kalliampakou, K. I., Milona, R. S., Kyriakopoulou, E., Mpekoulis, G., Gemenetzi, I., Stylianaki, E.-A., Sideris, C. D., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2023.119602 · Cited by 6
The importance of choosing a preclinical model that reflects what happens in Parkinson's disease
Segura‐Aguilar, J. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.03.016 · Cited by 5
Self-citationMitochondrial Proteins in the Development of Parkinson’s Disease
Zilocchi, M., Fasano, M., & Alberio, T. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8367-0_2 · Cited by 5
Franco, R., Castelló, J., & Canela, E. I. (2019) · Current Neuropharmacology · doi:10.2174/1570159x17666191001144309 · Cited by 5
Bayo-Olugbami, A. A., Nafiu, A. B., Amin, A., Ogundele, O. M., Lee, C. C., & Owoyele, B. V. (2022) · Nigerian Journal of Physiological Sciences · doi:10.54548/njps.v37i2.3 · Cited by 8
El papel de las especies reactivas de oxígeno y nitrógeno en algunas enfermedades neurodegenerativas
Hernández-Espinosa, D. R., Morín, V. B., Tena, O. B., Herrera, E. A. G., Maldonado, K. D. L., Díaz, A. S. J., Olivares, M. S., & Matuz‐Mares, D. (2019) · Revista de la Facultad de Medicina UNAM · doi:10.22201/fm.24484865e.2019.62.3.03 · Cited by 14
A Druglike Ferrostatin‐1 Analogue as a Ferroptosis Inhibitor and Photoluminescent Indicator
Yan, J., Bao, L., Liang, H., Zhao, L., Liu, M., Kong, L., Fan, X., Liang, C., Liu, T., Han, X., et al. (2025) · Angewandte Chemie · doi:10.1002/ange.202502195 · Cited by 9
Mechanisms of Dopamine Oxidation and Parkinson’s Disease
Segura‐Aguilar, J., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_16 · Cited by 3
Self-citationAdrenochrome formation during photochemical decomposition of “caged” epinephrine derivatives
Starodubtseva, E. S., Karogodina, T. Y., Панфилов, М. А., Sheven, D. G., Selyutina, O. Y., Vorob’ev, A. Y., & Moskalensky, A. E. (2024) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-024-00665-9 · Cited by 3
“Dopamine also oxidizes in aminochrome, which plays a principal role in the formation of neuromelanin [17].”
Lee, H., Kim, H., Min, J., Lee, E. H., Choi, D. K., Choi, J., Seo, Y., Lee, S., Im, C. Y., Bae, G. H., et al. (2025) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70057 · Cited by 3
Muñoz, P., Meléndez, C., Paris, I. B., & Segura‐Aguilar, J. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13939-5_11 · Cited by 6
Self-citationGenes involved in the development of Parkinson
Teixeira, D., & Cardoso, I. (2017) · Open Journal of Parkinson s Disease and Treatment · doi:10.17352/ojpdt.000005 · Cited by 3
“This reaction is catalyzed by metals, oxygen or enzymes like tyrosinase [44].”
BackgroundInfluence of a Constant Magnetic Field on the Mechanism of Adrenaline Oxidation
Казин, В. Н., Guzov, E. A., Moshareva, V. A., & Плисс, Е. М. (2022) · Magnetochemistry · doi:10.3390/magnetochemistry8070070 · Cited by 3
Tang, F., Liu, H., Zhang, X. J., Zheng, H., Dai, Y. M., Zheng, L. Y., Yang, W. H., Du, Y. Y., & Liu, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.865825 · Cited by 2
Mechanisms of Dopamine Oxidation and Parkinson’s Disease
Segura‐Aguilar, J., & Paris, I. B. (2022) · Springer eBooks · doi:10.1007/978-3-030-71519-9_16-1 · Cited by 5
Self-citationSirota, T. V. (2014) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750814040088 · Cited by 2
García-Carmona, J. A., Amores-Iniesta, J., Soler-Usero, J., Cerdán-Sánchez, M. C., Zaragoza, J. N., López-López, M., Soria-Torrecillas, J. J., Ballesteros-Arenas, A., Pérez-Vicente, J. A., & Almela, P. (2023) · Genes · doi:10.3390/genes14071320 · Cited by 2
Lee, H., Kim, H., Choi, D. K., Ko, E., Choi, J., Seo, Y., Lee, S., Kim, S., Jung, S., Kim, M., et al. (2023) · Pharmacology Research & Perspectives · doi:10.1002/prp2.1135 · Cited by 1
Automated microuidic cell culture of stem cell derived dopaminergic neurons in Parkinson’s diseasePreprint
Kane, K. I. W., Moreno, E. L., Hachi, S., Walter, M., Jarazo, J., Hankemeier, T., Vulto, P., Schwamborn, J. C., Thoma, M., & Fleming, R. M. T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/209957 · Cited by 2
Neuronal hyperactivity in a LRRK2-G2019S cellular model of Parkinson’s DiseasePreprint
Moreno, E. L., Hachi, S., Nickels, S., Kane, K. I. W., Moein, M., Schwamborn, J. C., Skupin, A., Berghe, P. V., & Fleming, R. M. T. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.23.449591 · Cited by 2
“Dopaminergic neurons produce the neurotransmitter dopamine, which plays a central role in brain function [12, 52, 41].”
Backgroundde Ora, L. O., Uyeda, K. S., & Bess, E. N. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.08.495350 · Cited by 2
Upregulation of steroidogenesis is associated with coma in human cerebral malariaPreprint
Abdrabou, W. S., Gupta, H., Sahu, P. K., Mohanty, D., Pattnaik, R., Hoffmann, A., Mohanty, S., Wassmer, S. C., & Idaghdour, Y. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.01.538900 · Cited by 2
Asiago, J. M., Doyle, T. B., Mishra, V. R., Jacquet, A. D. R., & Rochet, J. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00325 · Cited by 1
Geng, D. (2023) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2023.49.007771 · Cited by 1
Çiçekli, E., Okuyan, H. M., Okuyan, C. B., Ayçiçek, Ş. Ö., & Kotan, D. (2025) · Brain and Behavior · doi:10.1002/brb3.70172 · Cited by 1
Guo, D., Chen, Y., Wu, Y., Cheng, J., Lin, Y., Ma, W., Ma, W., Yang, H., Ma, L., Ma, L., et al. (2026) · Microbiome · doi:10.1186/s40168-026-02433-6 · Cited by 3
“The melanin synthesis pathway has been previously reported [100–102].”
Meena, J., Santhakumar, K., & Kumar, A. S. (2025) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5c03030 · Cited by 1
Neuroprotective Attributes of Gut-derived Urolithins in Parkinson’s Disease
Chhetry, S., Roy, A., Roy, R., Bhattacharya, P., Tapias, V., & Borah, A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05541-w · Cited by 1
“Despite substantial therapeutic advances, current clinical management remains largely palliative, focusing on symptomatic relief rather than modifying disease progression [48, 49].”
Chawre, Y., Satnami, M. L., Kujur, A. B., Sinha, A., Soni, P. K., Miri, P., Nagwanshi, R., Karbhal, I., & Ghosh, K. K. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00937 · Cited by 1
Synthesis and bioactivity of 1-substituted tetrahydroisoquinolines derived from phenolic aldehydes
Dizdar, M., Maksimović, M., Topčagić, A., Avdić, M., & Vidić, D. (2023) · Organic Communications · doi:10.25135/acg.oc.159.2310.2920 · Cited by 8
“However, by reducing the degree of hydroxylation, mechanistic studies proved the formation of p -quinone through a one-electron mechanism 25,26 .”
BackgroundEvaluations of neurochemicals at surfactant modified electrochemical sensors and biosensors
Turan, K., Er, E., Uçar, A., & Tığ, G. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15493-5.00016-6 · Cited by 1
Fumaria vaillantii extract protects PC12 cells against neurotoxicity induced by 6-OHDA
Javid, H., Rahimian, R., Salimi, M., Haghani-Samani, E., Farhadi, M., & Torkaman‐Boutorabi, A. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09673-5 · Cited by 1
“Many sources and mechanisms are involved in brain ROS production, including the electron transport chain [11], auto-oxidation of dopamine [12], monoamine oxidase (MAO), NADPH oxidase (NOX) and intracellular calcium dysregulation [13].”
Preclinical models based on endogenous neurotoxins
Segura‐Aguilar, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822120-4.00011-3 · Cited by 2
Self-citationMicronutrients and Parkinson’s Disease
Azmin, S., Rani, R. M., & Ibrahim, N. M. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_9 · Cited by 1
Amphetamine and the Biology of Neuronal Morphology
Tendilla‐Beltrán, H., Arroyo‐García, L. E., & Flores, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_115 · Cited by 1
Dopamine and Serotonin Metabolism in Parkinsonian Models
Barrigon, C. D. L. F. (2018) · UCL Discovery (University College London) · Cited by 1
Amelioration of L-DOPA-induced dyskinesia with vitamin D 3 in Parkinsonian mice modelPreprint
Bayo-Olugbami, A. A., Nafiu, A. B., Amin, A., Ogundele, O. M., Lee, C. C., & Owoyele, B. V. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.13.459937 · Cited by 1
“The expression of DDC was not changed following treatment with VD3 compared with dyskinetic mice whereas, amantadine significantly increased DDC expression compared with dyskinesia [Figure 4B: F (3, 7) = 128.”
BackgroundResultInfluentialMetabolism of Neurotransmitters
Merino, P. (2019) · Wiley eBooks · doi:10.1002/9783527813421.ch7 · Cited by 1
Neuropharmacology and toxicology of novel amphetamine-type stimulants
den Hollander, B. (2015)
Chavarria, D. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/45cb-0p93
Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson’s Disease
Vasquez, V., Mitra, J., Guerrero, E. N., Hegde, P. M., Rao, K. S. J., & Hegde, M. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_5
Machine learning discriminates parkinsonian movement disorders in zebrafish
Hughes, G. L. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Peethambaran, B., Leonce, C., & Patel, A. (2021) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2021.14.00528
Modulation of neuronal function by tau, alpha synuclein or carbon dioxide
Hill, E. (2026) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33830401
Amphetamine and the Biology of Neuronal Morphology
Tendilla‐Beltrán, H., Arroyo‐García, L. E., & Flores, G. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_115-1 · Cited by 1
Sirota, T. V. (2020) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s199075082001014x
Bikri, S., Aboussaleh, Y., & Fouad, F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00011-7 · Cited by 1
Metadata
- Authors
- Muñoz, P., Huenchuguala, S., Paris, I., & Segura-Aguilar, J.
- Affiliations
- University of Chile (CL)
- Universidad Santo Tomás (CL)
- Molecular & Clinical Pharmacology, ICBM, Faculty of Medicine, University of Chile, Independencia 1027, Santiago 8380453, Chile
- Venue
- Parkinson's Disease
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-13
- ISSN
- 2042-0080 (ISSN-L)
- 2090-8083
- PMC
- PMC3433151
- OpenAlex
- W2096782959
- Cited by
- 214
- References
- 75
- Citations by year
- 2026: 13 · 2025: 18 · 2024: 9 · 2023: 20 · 2022: 25 · 2021: 22 · 2020: 15 · 2019: 23 · 2018: 12 · 2017: 16 · 2016: 12 · 2015: 11 · 2014: 14 · 2013: 4
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Parkinson s Disease (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- Fondo Nacional de Desarrollo Científico y Tecnológico (1100165)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- dopamine oxidation, aminochrome, neuromelanin, autophagy dysfunction, dopaminergic neurons, chaperone-mediated autophagy, mitochondrial dysfunction, oxidative stress, neuroinflammation, protein degradation, lysosome fusion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.